查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387955

2024年无创产前检测全球市场报告

Non-invasive Prenatal Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

2023年无创产前检测市场最大的地区将是北美。西欧是非侵入性产前检测市场的第二大地区。非侵入性产前检测市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 无创产前检测市场特点

第三章 非侵入性产前检测市场趋势及策略

第四章无创产前检测市场-宏观经济情景

第五章 全球无创产前检测市场规模及成长

  • 全球无创产前检测市场的驱动因素与阻碍因素
    • 市场驱动力
    • 市场抑制因素
  • 2018-2023年全球无创产前检测市场规模实绩及成长
  • 2023-2028、2033年全球无创产前检测市场规模及成长预测

第六章 无创产前检测市场区隔

  • 全球无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 消耗品
  • 装置
  • 全球无创产前检测市场，按设备细分，实绩和预测，2018-2023、2023-2028、2033
  • NGS系统
  • 聚合酶连锁反应（PCR）装置
  • 微阵列
  • 超音波设备
  • 其他（离心机）
  • 全球非侵入性产前检测市场，依耗材细分，实绩与预测，2018-2023年、2023-2028年、2033年
  • 检测套件/试剂
  • 免洗用品
  • 全球无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 三体性
  • 微缺失
  • 遗传学
  • Rh因子
  • 全球无创产前检测市场，按最终用户细分、实绩和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊断实验室

第七章无创产前检测市场区域与国家分析

  • 全球无创产前检测市场，按地区、实绩和预测，2018-2023、2023-2028、2033
  • 全球无创产前检测市场，依国家、实绩及预测，2018-2023、2023-2028、2033

第八章亚太无创产前检测市场

  • 亚太地区无创产前检测市场概况
  • 区域资讯、COVID-19疾病的影响、市场资讯、背景资讯、政府配合措施、法规、监管机构、主要组织、课税、企业税务结构、投资、主要企业
  • 亚太地区无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 亚太地区无创产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 亚太地区无创产前检测市场，依最终用户细分，实绩与预测，2018-2023、2023-2028、2033

第九章 中国无创产前检测市场

  • 中国无创产前检测市场概况
  • 中国无创产前检测市场，按类型细分、实绩与预测，2018-2023年、2023-2028年、2033年
  • 中国无创产前检测市场，依应用细分、实绩与预测，2018-2023年、2023-2028年、2033年
  • 中国无创产前检测市场，依最终用户细分、实绩及预测，2018-2023年、2023-2028年、2033年

第十章 印度无创产前检测市场

  • 印度无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 印度无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 印度无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十一章 日本无创产前检查市场

  • 日本无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 日本无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 日本无创产前检测市场，依最终用户细分，实绩与预测，2018-2023、2023-2028、2033

第十二章 澳洲无创产前检测市场

  • 澳洲无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 澳洲无创产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 澳洲无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十三章 印尼无创产前检测市场

  • 印尼无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 印尼无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 印尼无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十四章 韩国无创产前检测市场

  • 韩国无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 韩国无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 韩国无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十五章 西欧无创产前检测市场

  • 西欧无创产前检测市场概况
  • 西欧无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 西欧无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 西欧无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十六章英国无创产前检测市场

  • 英国无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 英国无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 英国无创产前检测市场，按最终用户细分、实绩和预测，2018-2023、2023-2028、2033

第十七章 德国无创产前检测市场

  • 德国无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 德国无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 德国无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十八章 法国无创产前检测市场

  • 法国无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 法国无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 法国无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第十九章 义大利无创产前检测市场

  • 义大利无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 义大利无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 义大利无创产前检测市场，依最终用户细分，实绩与预测，2018-2023、2023-2028、2033

第二十章 西班牙无创产前检测市场

  • 西班牙无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 西班牙无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 西班牙无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第21章 东欧无创产前检测市场

  • 东欧无创产前检测市场概况
  • 东欧无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 东欧无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 东欧无创产前检测市场，依最终用户细分、实绩与预测，2018-2023、2023-2028、2033

第22章 俄罗斯无创产前检测市场

  • 俄罗斯无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 俄罗斯无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 俄罗斯无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第23章 北美无创产前检测市场

  • 北美无创产前检测市场概况
  • 北美无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 北美非侵入性产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 北美无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第24章美国无创产前检测市场

  • 美国无创产前检测市场概况
  • 美国非侵入性产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 美国无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 美国无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第25章 加拿大无创产前检测市场

  • 加拿大无创产前检测市场概况
  • 加拿大无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 加拿大无创产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 加拿大无创产前检测市场，按最终用户细分、实绩和预测，2018-2023、2023-2028、2033

第26章 南美洲无创产前检测市场

  • 南美洲无创产前检测市场概况
  • 南美洲无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 南美洲无创产前检测市场，按应用细分、实绩和预测，2018-2023、2023-2028、2033
  • 南美洲无创产前检测市场，依最终用户细分，实绩与预测，2018-2023、2023-2028、2033

第27章 巴西无创产前检测市场

  • 巴西无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 巴西无创产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 巴西无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第28章 中东无创产前检测市场

  • 中东无创产前检测市场概况
  • 中东无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 中东无创产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 中东无创产前检测市场，依最终用户细分、实绩与预测，2018-2023、2023-2028、2033

第29章 非洲无创产前检测市场

  • 非洲无创产前检测市场概况
  • 非洲无创产前检测市场，按类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 非洲无创产前检测市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 非洲无创产前检测市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033

第30章 无创产前检测市场竞争形势及企业概况

  • 非侵入性产前检测市场竞争形势
  • 无创产前检测市场公司概况
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Natera Inc.
    • PerkinElmer Inc

第三十一章 全球无创产前检测市场竞争基准化分析

第32章全球无创产前检测市场竞争仪錶板

第三十三章 非侵入性产前检测市场重大併购

第34章 非侵入性产前检测市场未来前景及潜力分析

  • Non-invasive Prenatal Testing Market In 2028-Countries Offering Most New Opportunities
  • Non-invasive Prenatal Testing Market In 2028-Segments Offering Most New Opportunities
  • Non-invasive Prenatal Testing Market In 2028-Growth Strategies
  • Market Trend Based Strategies
  • Competitor Strategies

第35章附录

简介目录
Product Code: r9197

“Non-invasive Prenatal Testing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-invasive prenatal testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-invasive prenatal testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The non-invasive prenatal testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Consumables; Instruments
  • 2) By Application: Trisomy; Microdeletion; Genetics; Rh factor
  • 3) By End User: Hospital; Diagnostic Labs
  • Subsegment: NGS Systems; PCR Instruments; Microarrays; Ultrasound Devices; Others(Centrifuges; UV Systems; Incubators; Microscopes); Assay Kits &Reagents; Disposables
  • Companies Mentioned: F. Hoffmann-La Roche AG; Illumina Inc.; Laboratory Corporation of America Holdings; Natera Inc.; PerkinElmer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Non-invasive prenatal testing (NIPT) is a procedure where maternal blood is drawn and analyzed to detect potential abnormalities in the developing fetus. Non-invasive prenatal testing kits and equipment serve the purpose of identifying genetic irregularities, primarily chromosome defects, during the first trimester of pregnancy.

The key categories of non-invasive prenatal testing encompass consumables and instruments. Consumables refer to products that are used and depleted during their application. Instruments include NGS systems, PCR instruments, microarrays, ultrasound devices, and other equipment like centrifuges, UV systems, incubators, and microscopes. Various consumables comprise assay kits and reagents, as well as disposables. These applications pertain to the detection of conditions such as trisomy, microdeletion, genetics, and the Rh factor, and are typically employed by hospitals and diagnostic laboratories.

The non-invasive prenatal testing market research report is one of a series of new reports from The Business Research Company that provides non-invasive prenatal testing market statistics, including non-invasive prenatal testing industry global market size, regional shares, competitors with a non-invasive prenatal testing market share, detailed non-invasive prenatal testing market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive prenatal testing industry. This non-invasive prenatal testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $4.73 billion in 2023 to $5.44 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth observed during the historical period can be attributed to factors such as enhanced accuracy, decreased risk, the trend of increasing maternal age, heightened awareness, and the influence of clinical guidelines.

The non-invasive prenatal testing market size is expected to see rapid growth in the next few years. It will grow to $9.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The anticipated growth in the forecast period can be linked to the expansion of test offerings, increased accessibility, a rising trend in maternal age, the enhanced detection of fetal anomalies, and the influence of telemedicine and digital health. Prominent trends in this forecast period include the broadening of test panels, the widespread adoption of non-invasive prenatal testing (NIPT), technological advancements, and the development of non-invasive fetal aneuploidy diagnosis (NIFAD).

The high incidence rate of Down syndrome is a significant factor propelling the growth of the non-invasive prenatal testing (NIPT) market, especially with the increasing trend of older maternal age, which raises concerns about fetal well-being. Down syndrome, a chromosomal condition resulting from an error in cell division, leads to an extra chromosome 21 and can impact the cognitive and physical development of the fetus. NIPT screening tests offer a safe and non-invasive means of detecting Down syndrome, posing no harm to the mother or baby and carrying no risk of miscarriage. These tests can identify over 99% of Down syndrome cases. In the USA, the National Down Syndrome Society and the Centers for Disease Control and Prevention report that 1 in every 700 babies is born with Down syndrome, and 80% of children with Down syndrome are born to older mothers. The increased risk associated with advanced maternal age is a driving force behind the growth of the NIPT market.

The increasing maternal age is expected to be a key driver of the non-invasive prenatal testing market's expansion in the foreseeable future. Factors such as pursuing education, career opportunities, financial stability, personal choices, delayed marriage, improved contraception, and societal changes have led to women delaying childbirth. This delay increases the risk of chromosomal abnormalities, prompting more expectant mothers to opt for NIPT to assess their pregnancy's health. For example, data from the Centers for Disease Control and Prevention in June 2023 indicates a 2% increase in the provisional birth rate for women aged 35-39 from 2021 to 2022, with a 2% rise in the number of births to women in their late 30s. Additionally, the provisional birth rate for women aged 40-44 increased by 4% from 2021 to 2022, with a 6% rise in the number of births to these women. The provisional birth rate for women aged 45-49 (including those aged 50 and older) increased by 1.1 births per 1,000 women in 2022, up from 0.9 in 2021, marking the first change in this rate since 2015 and a 12% increase in the number of births to women in this age group. Therefore, increasing maternal age will continue to drive the growth of the non-invasive prenatal testing market.

The non-invasive prenatal testing (NIPT) market faces ethical challenges, particularly concerning issues related to sex selection and the abortion of fetuses with chromosomal abnormalities. Determining the sex of the fetus or identifying abnormalities at an early stage has raised ethical concerns, leading to stricter regulations on the use of such diagnostic tools. In the UK, a record 214,869 abortions were performed in England and Wales in 2021, the highest number since abortion became legal in 1967. These ethical dilemmas can pose constraints on the non-invasive prenatal testing market.

The integration of next-generation sequencing technology has significantly enhanced the capabilities of researchers, enabling them to conduct a wide range of applications and study biological systems at a higher level. Next-generation sequencing allows for the simultaneous sequencing of thousands to millions of DNA molecules, reducing both time and cost while optimizing results for genome and DNA testing. Major companies like Illumina, Eurofins, Natera, Roche, and Annoroad have adopted this technology for non-invasive prenatal testing. The China Food and Drug Administration (CFDA) has approved the medical instrument product registration for Annoroad's NGS instrument NextSeq 550AR.

The non-invasive prenatal testing market is subject to strict regulation by various international and country-specific agencies. For instance, the US Food and Drug Administration (FDA) issues certifications for Laboratory Developed Tests (LDTs) and Clinical Laboratory Improvement Amendments (CLIA). Manufacturers must obtain a 510(k) premarket notification for in vitro diagnostic tests, with LDTs and CLIA certification based on the number of tests conducted during clinical trials. For instance, for trisomy 21 (Down syndrome), with an incidence rate of 1/1000, at least 100,000 samples would need to be tested to meet the requirements of a 510(k). A 510(k) premarket notification ensures that the new product is as safe and effective as other legally-marketed devices, and manufacturers must register such notifications before commercially marketing new products.

In May 2021, Echelon Diagnostics, a US-based leader in genomic healthcare AI imaging analysis and big data solutions, signed a collaboration agreement with Cradle Genomics for an undisclosed amount. This partnership aims to accelerate the development of Cradle's cellular-based non-invasive prenatal diagnostic (NIPD) products. Cradle Genomics, a US-based company specializing in non-invasive prenatal testing services, offers diagnostic solutions.

Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health PLC, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the non-invasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The non-invasive prenatal testing market includes revenue earned by ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests, and biochemical screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Non-invasive Prenatal Testing Market Characteristics

3. Non-invasive Prenatal Testing Market Trends And Strategies

4. Non-invasive Prenatal Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Non-invasive Prenatal Testing Market Size and Growth

  • 5.1. Global Non-invasive Prenatal Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Non-invasive Prenatal Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Non-invasive Prenatal Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-invasive Prenatal Testing Market Segmentation

  • 6.1. Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
  • 6.2. Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • NGS Systems
  • Polymerase Chain Reaction (PCR) Instruments
  • Microarrays
  • Ultrasound Devices
  • Others(Centrifuges
  • 6.3. Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Assay Kits And Reagents
  • Disposables
  • 6.4. Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Trisomy
  • Microdeletion
  • Genetics
  • Rh factor
  • 6.5. Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostic Labs

7. Non-invasive Prenatal Testing Market Regional And Country Analysis

  • 7.1. Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-invasive Prenatal Testing Market

  • 8.1. Asia-Pacific Non-invasive Prenatal Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-invasive Prenatal Testing Market

  • 9.1. China Non-invasive Prenatal Testing Market Overview
  • 9.2. China Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-invasive Prenatal Testing Market

  • 10.1. India Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-invasive Prenatal Testing Market

  • 11.1. Japan Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-invasive Prenatal Testing Market

  • 12.1. Australia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-invasive Prenatal Testing Market

  • 13.1. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-invasive Prenatal Testing Market

  • 14.1. South Korea Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-invasive Prenatal Testing Market

  • 15.1. Western Europe Non-invasive Prenatal Testing Market Overview
  • 15.2. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-invasive Prenatal Testing Market

  • 16.1. UK Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-invasive Prenatal Testing Market

  • 17.1. Germany Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-invasive Prenatal Testing Market

  • 18.5. France Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-invasive Prenatal Testing Market

  • 19.9. Italy Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-invasive Prenatal Testing Market

  • 20.13. Spain Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-invasive Prenatal Testing Market

  • 21.1. Eastern Europe Non-invasive Prenatal Testing Market Overview
  • 21.2. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-invasive Prenatal Testing Market

  • 22.1. Russia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-invasive Prenatal Testing Market

  • 23.1. North America Non-invasive Prenatal Testing Market Overview
  • 23.2. North America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-invasive Prenatal Testing Market

  • 24.1. USA Non-invasive Prenatal Testing Market Overview
  • 24.2. USA Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-invasive Prenatal Testing Market

  • 25.1. Canada Non-invasive Prenatal Testing Market Overview
  • 25.2. Canada Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-invasive Prenatal Testing Market

  • 26.1. South America Non-invasive Prenatal Testing Market Overview
  • 26.2. South America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-invasive Prenatal Testing Market

  • 27.1. Brazil Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-invasive Prenatal Testing Market

  • 28.1. Middle East Non-invasive Prenatal Testing Market Overview
  • 28.2. Middle East Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-invasive Prenatal Testing Market

  • 29.1. Africa Non-invasive Prenatal Testing Market Overview
  • 29.2. Africa Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-invasive Prenatal Testing Market Competitive Landscape And Company Profiles

  • 30.1. Non-invasive Prenatal Testing Market Competitive Landscape
  • 30.2. Non-invasive Prenatal Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Illumina Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Laboratory Corporation of America Holdings
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Natera Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. PerkinElmer Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Non-invasive Prenatal Testing Market Competitive Benchmarking

32. Global Non-invasive Prenatal Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Non-invasive Prenatal Testing Market

34. Non-invasive Prenatal Testing Market Future Outlook and Potential Analysis

  • 34.1 Non-invasive Prenatal Testing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Non-invasive Prenatal Testing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Non-invasive Prenatal Testing Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer